West Pharmaceutical Services · Operating Cash Flow (Statement)

Latest reported$662.20Mperiod endingJun 30, 2026

WST Cash from Operations ($42.90M → $662.20M)

Annual operating cash flow (statement)

High-resolution chart · PNG

WST operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	754,800,000
Dec 31, 2024	653,400,000
Dec 31, 2023	776,500,000
Dec 31, 2022	724,000,000
Dec 31, 2021	584,000,000
Dec 31, 2020	472,500,000
Dec 31, 2019	367,200,000
Dec 31, 2018	288,600,000
Dec 31, 2017	263,300,000
Dec 31, 2016	219,400,000
Dec 31, 2015	212,400,000
Dec 31, 2014	182,900,000
Dec 31, 2013	220,500,000
Dec 31, 2012	187,400,000
Dec 31, 2011	130,700,000
Dec 31, 2010	138,300,000
Dec 31, 2009	137,700,000
Dec 31, 2008	135,000,000
Dec 31, 2007	129,200,000
Dec 31, 2006	143,800,000
Dec 31, 2005	85,600,000
Dec 31, 2004	68,900,000
Dec 31, 2003	69,200,000
Dec 31, 2002	53,900,000
Dec 31, 2001	32,700,000
Dec 31, 2000	48,600,000
Dec 31, 1999	69,400,000
Dec 31, 1998	71,000,000
Dec 31, 1997	67,700,000
Dec 31, 1996	63,400,000
Dec 31, 1995	46,100,000
Dec 31, 1994	49,800,000
Dec 31, 1993	38,500,000
Dec 31, 1992	34,000,000
Dec 31, 1991	44,400,000
Dec 31, 1990	36,000,000
Dec 31, 1989	42,900,000